Navigation Links
PM Versus MIM: TM&S President to Explain Niche Metal Fabrication Methods During IHS GlobalSpec Event
Date:9/24/2013

Minneapolis, Minnesota (PRWEB) September 24, 2013

Derek Rasmussen, President of TM&S, LLC, will present “Powder Metal Part Design Fundamentals,” a free Webinar taking place on October 23, 2013, at 12:30 P.M. EST, during IHS GlobalSpec’s Aerospace Technology online event.

The informational session will help engineering, sales, and other professionals involved in component design for manufacture (DFM) understand the characteristics and best uses for Press and Sinter (conventional powder metal, or PM) and Metal Injection Molding (MIM), respectively. Both are classified as powder metal technologies and are used in the medical device, computer, communications, automotive, firearms, defense, aerospace, and consumer electronics industries. But there are vast differences between them in terms of manufacturing processes and capabilities.

With 20 years’ experience in component design, mold design, part processing, and troubleshooting high-volume manufacturing processes to increase yields, Mr. Rasmussen is uniquely qualified to give attendees a fundamental comparison of PM and MIM manufacturing technologies. His Webinar will help participants improve their cost analysis and sourcing decisions, as well as enhance communication with suppliers.

TM&S, LLC, is a trusted resource for custom component designers and manufacturers. It exclusively represents four companies specializing in niche powder metal technologies: ecoMIM of Retsag, Hungary (Metal Injection Molding); element22 of Kiel, Germany (Titanium MIM); FMS Corporation of Minneapolis, Minnesota (Press and Sinter and Micro MIM); and Liquidmetal Technologies of Rancho Santa Margarita, California. Their complementary capabilities allow TM&S to provide the best solution for any component suited to powder metal technology, whether round parts, complex geometric profiles, micro parts with high tolerances, or low-cost Titanium parts.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11150788.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Lillys Investigational GLP-1 Receptor Agonist, Dulaglutide, Showed Superior Glycemic Control Versus Comparators in Patients with Type 2 Diabetes
2. TM&S Opens Office Dedicated to Powder Metal, Metal Injection Molding and Liquid Metal
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Elsevier / MEDai Appoints Tom Zajac as New President
5. GenVec President and Chief Executive Officer Announces Retirement
6. Michael A. Marletta Takes Office as New President of Scripps Research Institute
7. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
8. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
9. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
10. Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO
11. Cepheid Welcomes Senior Vice President of Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , ... January 17, 2017 ... ... surgeons at the 2016 annual meeting of the North American Spine Society ... for patients in the majority of cases, when PEEK-OPTIMA™ HA Enhanced is ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, ... recently announced a collaboration with the Heidelberg University Hospital and the German Cancer ... preparation, following the company’s successful launch of its CATS (Capture and Amplification ...
(Date:1/16/2017)... 16, 2017   Valentin A. Pavlov, PhD , ... president and CEO of The Feinstein Institute for ... of how the nervous system regulates the immune system, ... bioelectronic medicine devices to treat disease and injury. ... . The paper examines various studies which ...
(Date:1/14/2017)... ARLINGTON, Va. , Jan. 13, 2017  The ... following statement in response to FDA final guidance ... FDA for its continued leadership in emphasizing the importance ... members are keenly aware of the benefits biosimilars will ... costs.   Yet the portion of the ...
Breaking Biology Technology:
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... LONDON , Dec. 7, 2016   Avanade ... most successful Formula One teams in history, exploit biometric ... pit stop performance and maintain the competitive edge against ... in 2016. Avanade has worked with ... a range of biometric data (heart rate, breathing rate, ...
Breaking Biology News(10 mins):